METHODS FOR DIAGNOSIS AND MONITORING USING URINE PROTEINS AS MARKERS IN IGA NEPHROPATHY

A method for diagnosis of IgA nephropathy is provided using a combination of alpha-1B-glycoprotein (A1BG) or a truncated fragment thereof having a molecular weight of 13-60 kDa, orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2) as protein markers in a urine sample from a subject.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FORONCEWICZ, BARTOSZ, PIWOWARSKI, JAN, MARCINKOWSKI, MICHAŁ, ZAGOŻDŻON, RADOSŁAW, DADLEZ, MICHAŁ, BAKUN, MAGDALENA, PĄCZEK, LESZEK, GARBICZ, DAMIAN, FLORCZAK, MICHAŁ, PILZYS, TOMAS, MUCHA, KRZYSZTOF, GRZESIUK, ELŻBIETA
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A method for diagnosis of IgA nephropathy is provided using a combination of alpha-1B-glycoprotein (A1BG) or a truncated fragment thereof having a molecular weight of 13-60 kDa, orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2) as protein markers in a urine sample from a subject.